idelalisib
thioguanine
venetoclax
chloraminophene
ponatinib
antileukemic
pegaspargase
tyrosine kinase inhibitor
acute lymphoblastic leukemia
alemtuzumab
antileukemia
promyeloleukemia
tafasitamab
roscovitine
ubenimex
acalabrutinib
506U78
fludarabine
alvocidib
leukemic
axicabtagene ciloleucel
axicabtagene
lumiliximab
vosaroxin
olutasidenib
asparaginase
Elspar
lymphocytotoxic
antilymphocyte
leukemogenicity
leukemogenic
trilaciclib
midostaurin
cytarabine
ofatumumab
lymphohyperplasia
omacetaxine
mogamulizumab
rituximab
capmatinib
piposulfan
lymphocytoma
afutuzumab
leukemogenically
cytotoxic drug
vismodegib
umbralisib
lymphocytolytic
acute lymphocytic leukemia
clofarabine
monalizumab
ivosidenib
ceritinib
thiotepa
rubitecan
chemodrug
lymphocytic leukemia
antilymphangiogenic
lymphosuppression
leucocrit
leucoblastoma
lymphoblastic leukemia
lymphoblast
lenzilumab
lymphangiostatic
bortezomib
migrastatic
leukemogenesis
dacarbazine
folinic acid
lymphographical
lymphoblastoid
leucovorin
mafosfamide
asciminib
lymphosuppressive
mannosulfan
hematogone
chronic lymphocytic leukemia
acute leukemia
talacotuzumab
aracytine
nonleukemic
picoplatin
immunocytometry
immunokinase
loncastuximab tesirine
leukoblastic
homoharringtonine
chemo
EPOCH
tazemetostat
osimertinib
cryptolepine
achroacytosis
acasunlimab